These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35727298)

  • 21. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
    Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
    Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer's Disease.
    Vlachakis D; Papakonstantinou E; Sagar R; Bacopoulou F; Exarchos T; Kourouthanassis P; Karyotis V; Vlamos P; Lyketsos C; Avramopoulos D; Mahairaki V
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociable influences of
    Ge T; Sabuncu MR; Smoller JW; Sperling RA; Mormino EC;
    Neurology; 2018 May; 90(18):e1605-e1612. PubMed ID: 29592889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of
    Xicota L; Gyorgy B; Grenier-Boley B; Lecoeur A; Fontaine G; Danjou F; Gonzalez JS; Colliot O; Amouyel P; Martin G; Levy M; Villain N; Habert MO; Dubois B; Lambert JC; Potier MC;
    Neurology; 2022 Aug; 99(5):e462-e475. PubMed ID: 35606148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polygenic risk scores for Alzheimer's disease, and academic achievement, cognitive and behavioural measures in children from the general population.
    Korologou-Linden R; Anderson EL; Jones HJ; Davey Smith G; Howe LD; Stergiakouli E
    Int J Epidemiol; 2019 Dec; 48(6):1972-1980. PubMed ID: 31056667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.
    Darst BF; Koscik RL; Racine AM; Oh JM; Krause RA; Carlsson CM; Zetterberg H; Blennow K; Christian BT; Bendlin BB; Okonkwo OC; Hogan KJ; Hermann BP; Sager MA; Asthana S; Johnson SC; Engelman CD
    J Alzheimers Dis; 2017; 55(2):473-484. PubMed ID: 27662287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole-exome sequencing of the BDR cohort: evidence to support the role of the PILRA gene in Alzheimer's disease.
    Patel T; Brookes KJ; Turton J; Chaudhury S; Guetta-Baranes T; Guerreiro R; Bras J; Hernandez D; Singleton A; Francis PT; Hardy J; Morgan K
    Neuropathol Appl Neurobiol; 2018 Aug; 44(5):506-521. PubMed ID: 29181857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimodal Brain Imaging Reveals Structural Differences in Alzheimer's Disease Polygenic Risk Carriers: A Study in Healthy Young Adults.
    Foley SF; Tansey KE; Caseras X; Lancaster T; Bracht T; Parker G; Hall J; Williams J; Linden DE
    Biol Psychiatry; 2017 Jan; 81(2):154-161. PubMed ID: 27157680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of an Alzheimer's disease polygenic risk score to identify mild cognitive impairment in adults in their 50s.
    Logue MW; Panizzon MS; Elman JA; Gillespie NA; Hatton SN; Gustavson DE; Andreassen OA; Dale AM; Franz CE; Lyons MJ; Neale MC; Reynolds CA; Tu X; Kremen WS
    Mol Psychiatry; 2019 Mar; 24(3):421-430. PubMed ID: 29487403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic Stratification to Identify Risk Groups for Alzheimer's Disease.
    Marioni RE; Campbell A; Hagenaars SP; Nagy R; Amador C; Hayward C; Porteous DJ; Visscher PM; Deary IJ
    J Alzheimers Dis; 2017; 57(1):275-283. PubMed ID: 28222519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polygenic risk scores for Alzheimer's disease in relation to cognitive change: A representative sample from the general population followed over 16 years.
    Najar J; Thorvaldsson V; Kern S; Skoog J; Waern M; Zetterberg H; Blennow K; Skoog I; Zettergren A
    Neurobiol Dis; 2023 Dec; 189():106357. PubMed ID: 37977433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative.
    Zettergren A; Lord J; Ashton NJ; Benedet AL; Karikari TK; Lantero Rodriguez J; ; Snellman A; Suárez-Calvet M; Proitsi P; Zetterberg H; Blennow K
    Alzheimers Res Ther; 2021 Jan; 13(1):17. PubMed ID: 33419453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polygenic impact of common genetic risk loci for Alzheimer's disease on cerebral blood flow in young individuals.
    Chandler HL; Wise RG; Murphy K; Tansey KE; Linden DEJ; Lancaster TM
    Sci Rep; 2019 Jan; 9(1):467. PubMed ID: 30679549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polygenic Risk Scores Derived From Varying Definitions of Depression and Risk of Depression.
    Mitchell BL; Thorp JG; Wu Y; Campos AI; Nyholt DR; Gordon SD; Whiteman DC; Olsen CM; Hickie IB; Martin NG; Medland SE; Wray NR; Byrne EM
    JAMA Psychiatry; 2021 Oct; 78(10):1152-1160. PubMed ID: 34379077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic overlap between Alzheimer's disease and blood lipid levels.
    van der Linden RJ; Reus LM; De Witte W; Tijms BM; Olde Rikkert M; Visser PJ; Poelmans G
    Neurobiol Aging; 2021 Dec; 108():189-195. PubMed ID: 34340865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mid to late-life scores of depression in the cognitively healthy are associated with cognitive status and Alzheimer's disease pathology at death.
    Robinson AC; Roncaroli F; Davidson YS; Minshull J; Heal C; Montaldi D; Payton A; Horan MA; Pendleton N; Mann DMA
    Int J Geriatr Psychiatry; 2021 May; 36(5):713-721. PubMed ID: 33176024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.
    Xu Y; Vasiljevic E; Deming YK; Jonaitis EM; Koscik RL; Van Hulle CA; Lu Q; Carboni M; Kollmorgen G; Wild N; Carlsson CM; Johnson SC; Zetterberg H; Blennow K; Engelman CD
    J Alzheimers Dis; 2023; 94(4):1587-1605. PubMed ID: 37482996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in Polygenic Composite Scores in Alzheimer's and Other Complex Diseases.
    Chasioti D; Yan J; Nho K; Saykin AJ
    Trends Genet; 2019 May; 35(5):371-382. PubMed ID: 30922659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pupillary dilation responses as a midlife indicator of risk for Alzheimer's disease: association with Alzheimer's disease polygenic risk.
    Kremen WS; Panizzon MS; Elman JA; Granholm EL; Andreassen OA; Dale AM; Gillespie NA; Gustavson DE; Logue MW; Lyons MJ; Neale MC; Reynolds CA; Whitsel N; Franz CE
    Neurobiol Aging; 2019 Nov; 83():114-121. PubMed ID: 31585363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.